Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model

Abstract

Background The triglyceride glucose (TyG) index is a well-established biomarker for insulin resistance (IR) that shows correlation with poor outcomes in patients with coronary artery disease. We aimed to integrate the TyG index with clinical data in a prediction nomogram for the long-term prognosis of new onset ST-elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI) . Methods This retrospective study included new-onset STEMI patients admitted at two heart centers for emergency PCI from December 2015 to March 2018 in development and independent validation cohorts. Potential risk factors were screened applying least absolute shrinkage and selection operator (LASSO) regression. Multiple Cox regression was employed to identify independent risk factors for prediction nomogram construction. Nomogram performance was assessed based on receiver operating characteristic curve analysis, calibration curves, Harrell’s C-index and decision curve analysis (DCA). Results In total, 404 patients were assigned to the development cohort and 169 to the independent validation cohort. The constructed nomogram included four clinical variables: age, diabetes mellitus, current smoking, and TyG index. The Harrell’s C-index values for the nomogram were 0.772 (95% confidence interval [CI]: 0.721–0.823) in the development cohort and 0.736 (95%CI: 0.656–0.816) in the independent validation cohort. Significant correlation was found between the predicted and actual outcomes in both cohorts, indicating that the nomogram is well calibrated. DCA confirmed the clinical value of the development prediction nomogram. Conclusions Our validated prediction nomogram based on the TyG index and electronic health records data was shown to provide accurate and reliable discrimination of new-onset STEMI patients at high- and low-risk for major adverse cardiac events at 2, 3 and 5 years following emergency PCI.

A glimpse into the future: revealing the key factors for survival in cognitively impaired patients

“…In recent years, nomograms have been increasingly used to diagnose and predict a variety of diseases, including cancer ( Balachandran et al, 2015 ), myocardial infarction ( Ye et al, 2023 ), and hypertension ( Zhang et al, 2022 ). The utilization of nomograms serves to simplify the interpretation of pertinent risk factors, aiding both clinicians and patients in navigating the challenges posed by diseases.…”

Development and validation of a nomogram to predict the recurrence of eyelid sebaceous gland carcinoma

“…Reliable nomograms can be of immense value in predicting the prognosis of eyelid tumors and other malignancies, assisting patients in decision-making, and aiding healthcare providers in personalizing clinical treatments. [30][31][32][33] The traditional AJCC classification system focuses on the tumor's largest diameter and invasion profile. However, our retrospective study showed that the degree of pathological differentiation, Ki67 expression, and pagetoid infiltration of the conjunctival epithelium could also increase the risk of recurrence, with specific predictive value.…”

Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services

“…Previous research has linked the clinical profile of ACS patients at admission to prognosis, with age, cardiac insufficiency, and blood pressure clinically recognized as independent markers of poor prognosis following PCI in ACS patients (34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53).…”